Intervention · Cellular energy
NAD+ therapy,
without the overpromise.
NAD+ is the coenzyme behind cellular energy and repair, and it measurably declines with age. The mechanism is real; the “reverse ageing” marketing outruns the human evidence. We deliver NAD+ precursors and supervised IV infusions at China’s Class A hospitals from $300 — and tell you exactly where the science stands.
Every cell
NAD+ is essential
Energy metabolism & repair coenzyme
Cell biology
Declines
With age
Well-documented across studies
Ageing research
Precursors
Raise NAD+ levels
NMN/NR proven to elevate NAD+
Human trials
Emerging
Healthspan evidence
Clinical payoff not yet proven
Honest grading
$300–1.5k
Per course
Below Western clinic pricing
Partner quotes 2026
Class A
Medical setting
Supervised infusion, not pop-ups
NHC
The molecule
Real mechanism,
honest expectations.
NAD+ sits at the centre of how cells make energy and repair themselves. Every mitochondrion relies on it; so do the DNA-repair enzymes and the longevity-linked sirtuins. It is genuinely one of the most important small molecules in your biology — and its levels fall measurably as you age.
That combination — essential coenzyme, age-related decline — is why NAD+ became a longevity-medicine staple. The preclinical data are compelling: restoring NAD+ improves metabolic and repair function in cells and animals. NAD+ precursors (NMN, NR) reliably raise NAD+ levels in people and appear safe.
But we draw the line clearly. Whether raising NAD+ delivers meaningful healthspan, energy or anti-ageing benefits in humans is not yet proven, and intravenous NAD+ in particular lacks large controlled trials. So we offer it as a well-tolerated, supportive option within an evidence-led plan — not as the “reverse ageing” cure it is often marketed as. It complements the longevity intervention layer rather than headlining it.
What NAD+ does
Four roles in the cell.
Mitochondrial energy
NAD+ carries electrons through the reactions that generate cellular energy (ATP). Without adequate NAD+, energy production falters — the rationale behind fatigue claims.
DNA & cell repair
Repair enzymes (PARPs) consume NAD+ to fix DNA damage. Chronic damage and inflammation drain the pool, leaving less for everyday maintenance.
Sirtuin activation
Longevity-associated sirtuin enzymes depend on NAD+ to regulate metabolism and stress responses — a key link in ageing-biology research.
Age-related decline
Tissue NAD+ falls with age. The supplementation rationale is to restore it toward youthful levels — a sound mechanism whose human payoff is still being tested.
How we position it
Four things we tell every patient.
The decline is real
Age-related NAD+ decline and the central role of NAD+ in metabolism are well established. The mechanism behind the interest is genuine, not invented.
The cure claims are not
Claims that NAD+ infusions reverse ageing or treat unrelated conditions outrun the human evidence. We grade NAD+ as a supportive, investigational intervention.
Supervised, sterile delivery
IV NAD+ must be infused slowly by trained staff in a medical facility. We deliver it only in Class A hospital settings — never in unsupervised drip bars.
Matched, not sold
We start from a clinical assessment and tell you honestly whether NAD+ is reasonable for you — rather than selling an infusion off a menu regardless of fit.
NAD+ therapy is positioned as a supportive, investigational intervention. Age-related NAD+ decline is well documented, but healthspan and anti-ageing benefits in humans are not yet proven, and IV NAD+ lacks large controlled trials. We deliver it only under medical supervision in Class A hospital settings and set realistic expectations up front.
The pathway
Assessed first,
infused second.
Clinical assessment
A physician reviews your goals, symptoms and baseline labs to decide whether an NAD+ protocol is reasonable for you — and which format fits — or recommends against it.
Protocol selection
Based on the assessment, we set an oral precursor (NMN/NR) regimen, an IV infusion series, or a combination, with clear, realistic expectations set up front.
Supervised delivery
IV NAD+ is infused slowly under medical supervision in a Class A hospital setting, with monitoring for transient infusion reactions. Oral protocols are dispensed with guidance.
Response review
We track tolerability and any subjective change against the baseline, and adjust the protocol — or stop it — based on what the evidence and your response support.
Integration
NAD+ is positioned within a broader, evidence-led healthspan plan (sleep, exercise, metabolic optimisation) rather than as a stand-alone fix, with bilingual records.
FAQ
NAD+ therapy, answered.
- What is NAD+ and why does it matter?
- NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell. It is central to two things: energy metabolism — it shuttles electrons in the mitochondrial reactions that produce cellular energy (ATP) — and cellular maintenance, acting as a substrate for repair enzymes (PARPs) and longevity-associated sirtuins. Because so much of cellular function depends on it, NAD+ has become a focus of ageing and metabolic research.
- Does NAD+ really decline with age?
- Yes — this part is well supported. Tissue NAD+ levels measurably decline with age across multiple studies, driven by both reduced synthesis and increased consumption by repair enzymes and chronic inflammation. The genuinely open question is the next step: whether raising NAD+ back toward youthful levels in humans translates into meaningful improvements in healthspan, energy or disease risk. The decline is real; the clinical payoff of reversing it is what remains to be proven.
- What does the human evidence for IV NAD+ actually show?
- We will be straight with you: the strongest data are preclinical (cells and animals), where NAD+ restoration shows clear metabolic and repair benefits. Human evidence is much thinner. NAD+ precursors (NMN and NR) reliably raise blood NAD+ levels in trials and appear safe, but consistent clinical benefits for energy, ageing or performance have not been firmly established. For intravenous NAD+ specifically, controlled clinical-outcome data are limited, and much of its popularity rests on anecdote and small studies rather than large randomised trials.
- Where is NAD+ best supported, and where is it hype?
- Best supported: NAD+ precursors raise NAD+ levels and have a reassuring safety record; there is mechanistic rationale and active, serious research. More speculative: claims that NAD+ infusions ‘reverse ageing,’ dramatically boost energy in healthy people, or treat a long list of unrelated conditions. There is also legitimate, separate research into NAD+ pathways in specific medical contexts. We position NAD+ as a plausible, well-tolerated supportive intervention with promising but unproven healthspan claims — not a validated anti-ageing cure.
- Is NAD+ therapy safe? What are the side effects?
- Oral precursors (NMN/NR) have been well tolerated in trials with no serious safety signals at studied doses. Intravenous NAD+ is generally well tolerated when administered slowly by trained staff at a medical facility; infusing too quickly is the main cause of the transient flushing, nausea, chest tightness or cramping that some people report, which is why infusion rate and clinical supervision matter. As with any IV therapy, sterility and proper monitoring are essential — which is why we deliver it only in Class A hospital settings, not pop-up clinics.
- How much does NAD+ therapy cost in China?
- All-in international-patient pricing runs roughly $300–$1,500 for a typical course depending on format (oral precursor protocol vs IV infusion series), dose and number of sessions, plus the clinical assessment. IV NAD+ infusion series sit at the higher end. Pricing is materially below the per-session rates charged by Western longevity and ‘drip’ clinics, and includes medical supervision in a Class A hospital setting.
- Can foreigners get NAD+ therapy in China?
- Yes. International patients access NAD+ protocols through the longevity, integrative and health-management departments of Class A hospitals, with bilingual coordination and physician oversight. Panda Touring Care arranges a clinical assessment (so the intervention is matched to you rather than sold off a menu), the protocol itself under medical supervision, and follow-up — and will tell you candidly where the evidence is strong and where it is not.
Continue exploring
Blood Purification
Therapeutic apheresis — its real medical indications and its limits.
Read on apheresisExosome Therapy
Cell-free MSC-derived vesicles for inflammatory and degenerative conditions.
Read on exosomesCellular Function Testing
Measure the mitochondrial and metabolic baseline NAD+ aims to support.
Read on cell functionStem Cell Therapy
The regenerative-medicine pillar — MSC therapy, honestly graded.
Read on stem cellsWT1 Cancer Vaccine
Where therapeutic cancer vaccines fit — and where they don't.
Read on WT1Longevity Medicine Hub
The full screening-and-intervention overview.
Back to hubIs NAD+ reasonable
for you?
Tell us your goals and baseline. A physician will tell you honestly whether an NAD+ protocol makes sense for you, what realistic expectations look like, and how it fits within a broader evidence-led healthspan plan.